Tetanus Toxoid Vaccine Market - 39% of Growth to Originate from North America| Evolving Opportunities with Actiza Pharmaceutical Pvt. Ltd. & Bharat Biotech Ltd. | Technavio

For more insights on the market share of various regions - Download a sample now!

Market Dynamics

The market is driven by factors such as the licensing agreements, rising cases of tetanus, diphtheria, and pertussis, and the increasing government initiatives regarding vaccination and immunization. However, the high cost of healthcare is hindering the market growth.  The holistic analysis of the drivers, trends & challenges will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Company Profiles

 The tetanus toxoid vaccine market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market. Some of the companies covered in this report are Actiza Pharmaceutical Pvt. Ltd., AJ Vaccines AS, Amson Vaccines and Pharma Pvt Ltd., Avalon Pharma Pvt. Ltd., Bharat Biotech Ltd., CSL Ltd., Dano Vaccines and Biologicals Pvt. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Grifols SA, Incepta Vaccine Ltd., Meiji Holdings Co. Ltd., Merck and Co. Inc., Microgen, Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., and Zoetis Inc., etc.

Few companies with key offerings

• Actiza Pharmaceutical Pvt. Ltd., - The company is involved in the manufacturing, export, and distribution of generic, branded, and other allied pharmaceutical products.
• Avalon Pharma Pvt. Ltd. - The company offers Tetanus toxoid vaccine adsorbed 5lf injection, which helps to develop immunity by initiating a mild infection.
• Bharat Biotech Ltd. - The company offers tetanus toxoid vaccines such as Comvac 3 and Comvac 4.
• Emergent -The company offers a tetanus toxoid vaccine named BioThrax (Anthrax Vaccine Adsorbed).
• GlaxoSmithKline Plc - The company offers Tetanus toxoid vaccines such as Boostrix and Boostrix IPV.
• To know about all major vendor offerings - Download a sample now!

Competitive Analysis

The competitive scenario provided in the tetanus toxoid vaccine market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc. Don't wait, Make a strategic approach & boost your business goals with our Tetanus Toxoid Vaccine Market Forecast Report - Buy Now!

Segmentation Analysis

• By Age Group, the market is classified into Neonatal and adults.
• By Geography, the market is classified as North America, Europe, Asia, and the Rest of the World (ROW). 

To know about the market contribution of each segment - Download a sample now!

Related Reports

• The Japanese encephalitis vaccine market share is expected to increase by USD 54.39 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 6%. Download a sample now!
• The vaccine market size is expected to be valued at USD 28.28 billion by 2026 with a progressing CAGR of 4.13%. Download a sample now!

Table of Content

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Age Group
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Age Group

• 5.1 Market segments
• Exhibit 24: Chart on Age Group - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Age Group - Market share 2021-2026 (%)

• 5.2 Comparison by Age Group
• Exhibit
  26: Chart on Comparison by Age Group
• Exhibit 27: Data Table on Comparison by Age Group

• 5.3 Neonatals - Market size and forecast 2021-2026
• Exhibit 28: Chart on Neonatals - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Neonatals - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Neonatals - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Neonatals - Year-over-year growth 2021-2026 (%)

• 5.4 Adults - Market size and forecast 2021-2026
• Exhibit 32: Chart on Adults - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Adults - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Adults - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Adults - Year-over-year growth 2021-2026 (%)

• 5.5 Market opportunity by Age Group
• Exhibit 36: Market opportunity by Age Group ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share by geography 2021-2026 (%)
• Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 UK - Market size and forecast 2021-2026
• Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.10 France - Market size and forecast 2021-2026
• Exhibit 70: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on France - Year-over-year growth 2021-2026 (%)

• 7.11 Canada - Market size and forecast 2021-2026
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification

• 10.3 Avalon Pharma Pvt. Ltd.
• Exhibit 85: Avalon Pharma Pvt. Ltd. - Overview
• Exhibit 86: Avalon Pharma Pvt. Ltd. - Product / Service
• Exhibit 87: Avalon Pharma Pvt. Ltd. - Key offerings

• 10.4 Bharat Biotech Ltd.
• Exhibit 88: Bharat Biotech Ltd. - Overview
• Exhibit 89: Bharat Biotech Ltd. - Product / Service
• Exhibit 90: Bharat Biotech Ltd. - Key news
• Exhibit 91: Bharat Biotech Ltd. - Key offerings

• 10.5 Emergent BioSolutions Inc.
• Exhibit 92: Emergent BioSolutions Inc. - Overview
• Exhibit 93: Emergent BioSolutions Inc. - Product / Service
• Exhibit 94: Emergent BioSolutions Inc. - Key news
• Exhibit 95: Emergent BioSolutions Inc. - Key offerings

• 10.6 GlaxoSmithKline Plc
• Exhibit 96: GlaxoSmithKline Plc - Overview
• Exhibit 97: GlaxoSmithKline Plc - Business segments
• Exhibit 98: GlaxoSmithKline Plc - Key news
• Exhibit 99: GlaxoSmithKline Plc - Key offerings
• Exhibit 100: GlaxoSmithKline Plc - Segment focus

• 10.7 Merck and Co. Inc.
• Exhibit 101: Merck and Co. Inc. - Overview
• Exhibit 102: Merck and Co. Inc. - Business segments
• Exhibit 103: Merck and Co. Inc. - Key news
• Exhibit 104: Merck and Co. Inc. - Key offerings
• Exhibit 105: Merck and Co. Inc. - Segment focus

• 10.8 Panacea Biotec Ltd.
• Exhibit 106: Panacea Biotec Ltd. - Overview
• Exhibit 107: Panacea Biotec Ltd. - Product / Service
• Exhibit 108: Panacea Biotec Ltd. - Key offerings

• 10.9 Pfizer Inc.
• Exhibit 109: Pfizer Inc. - Overview
• Exhibit 110: Pfizer Inc. - Product / Service
• Exhibit 111: Pfizer Inc. - Key news
• Exhibit 112: Pfizer Inc. - Key offerings

• 10.10 Sanofi
• Exhibit 113: Sanofi - Overview
• Exhibit 114: Sanofi - Business segments
• Exhibit 115: Sanofi - Key news
• Exhibit 116: Sanofi - Key offerings
• Exhibit 117: Sanofi - Segment focus

• 10.11 Serum Institute of India Pvt. Ltd.
• Exhibit 118: Serum Institute of India Pvt. Ltd. - Overview
• Exhibit 119: Serum Institute of India Pvt. Ltd. - Product / Service
• Exhibit 120: Serum Institute of India Pvt. Ltd. - Key offerings

• 10.12 Shenzhen Kangtai Biological Products Co. Ltd.
• Exhibit 121: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
• Exhibit 122: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
• Exhibit 123: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 124: Inclusions checklist
• Exhibit 125: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 126: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 127: Research methodology
• Exhibit 128: Validation techniques employed for market sizing
• Exhibit 129: Information sources

• 11.5 List of abbreviations
• Exhibit 130: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio